Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Glucagon is known to stimulate calcitonin secretion by thyroid C cells over a wide range of concentrations, raising the possibility of its interaction with several types of receptors. This study was designed to characterize receptors that mediate the effect of glucagon on a rat C cell line (CA-77). Binding studies, using radiolabeled [125I]glucagon and [125I]glucagon-like peptide-1-(7-36) amide ([125I]tGLP-1), to CA-77 plasma membranes demonstrated the presence of 1) a glucagon receptor with a dissociation constant (Kd) of 2.3 nM and relative potencies for structurally related peptides as follows: glucagon > oxyntomodulin > > tGLP-1; and 2) a tGLP-1 receptor with a Kd of 0.33 nM and relative potencies as follows: tGLP-1 > oxyntomodulin > glucagon. Glucagon stimulated calcitonin secretion from CA-77 cells in a dose-dependent manner over 4 orders of magnitude, with a maximal response of 312% over the basal value and an ED50 close to 50 nM. tGLP-1 induced a calcitonin release over 2 orders of magnitude, with a maximal response of 170% over the basal value and an ED50 close to 0.2 nM. Glucagon and tGLP-1 stimulated cAMP production in CA-77 cells to similar maximal levels over 4 and 2 orders of magnitude, respectively. The stimulation of cAMP production by glucagon at concentrations over 10 nM was suppressed by the tGLP-1 antagonist exendin-(9-39) amide, whereas the stimulation of calcitonin secretion was only partly abolished. Using a perifusion system of rat thyroid, glucagon and tGLP-1 stimulated calcitonin secretion in a calcium-dependent manner. It is concluded that glucagon and tGLP-1 receptors are expressed in the rat C cell line (CA-77) and in the normal rat thyroid. The effects of glucagon on calcitonin secretion observed at high concentrations are mediated in part through interaction with tGLP-1 receptors and via an additional non-cAMP-mediated mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering the expression of the GLP-1R in thyroid C cells and the ability of GLP-1 to stimulate calcitonin secretion through a cAMP-mediated mechanism in vitro, it is plausible that calcitonin plays a role in the alterations in bone metabolism observed in GLP-1R-treated animals.369,370”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [369]
In the citing paper
“Since GLP-1R is expressed in thyroid C cells and GLP-1 directly stimulates the secretion of calcitonin, which is a potent inhibitor of bone resorption in osteoclasts, GLP-1 may contribute to the nutrient-mediated reduction in bone resorption.369,370”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [369]
Citations
Cites
Radioimmunoassay for Cyclic Nucleotides
Steiner, A. L., Parker, C. W., & Kipnis, D. M. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45621-4 · Cited by 2,026
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
Holst, J. J., Ørskov, C., Vagn Nielsen, O., & Schwartz, T. W. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81430-8 · Cited by 615
ØRSKOV, C., HOLST, J. J., KNUHTSEN, S., BALDISSERA, F. G. A., POULSEN, S. S., & NIELSEN, O. V. (1986) · Endocrinology · doi:10.1210/endo-119-4-1467 · Cited by 482
Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450
Glucagonlike peptide 1: a newly discovered gastrointestinal hormone
Holst, J. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90831-1 · Cited by 252
Secretion of Proglucagon-Derived Peptides in Response to Intestinal Luminal Nutrients*
ROBERGE, J. N., & BRUBAKER, P. L. (1991) · Endocrinology · doi:10.1210/endo-128-6-3169 · Cited by 153
Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cells
Göke, R., & Conlon, J. M. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1160357 · Cited by 152
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“369,370 Later, quantitative real-time PCR analysis demonstrated that the administration of exendin-4, a GLP-1RA, resulted in signi fi cant upregulation of thyroid calcitonin mRNA levels in wild-type mice.”
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“It has been reported that GLP-1Rs are present in rat and murine thyroid C cells and that GLP-1 stimulates the secretion of calcitonin via a cAMP-dependent mechanism in cultured murine C cells (Crespel et al., 1996; Lamari et al., 1996).”
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1272 · Cited by 672
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Korner, M., Stockli, M., Waser, B., & Reubi, J. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038679 · Cited by 477
“Endocrine tumors Pheochromocytomas 12/20 (60) 3,970 6 1,002 Paragangliomas 5/18 (28) 1,353 6 601 Medullary thyroid carcinomas 5/18 (28) 1,326 6 264 Adrenal cortical adenomas 0/7 (0) Parathyroid carcinomas 0/4 (0) Pituitary adenomas 0/38 (0) Tumors of nervous system Meningiomas 7/20 (35) 989 6 271 Astrocytomas 4/16 (25…”
Influential
Metadata
- Authors
- Crespel, A., De Boisvilliers, F., Gros, L., & Kervran, A.
- Affiliations
- Inserm (FR)
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-09
- Volume
- 137
- Issue
- 9
- Pages
- 3674-3680
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2004507412
- Cited by
- 67
- References
- 36
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2022: 1 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 5 · 2015: 4 · 2014: 4 · 2013: 10 · 2012: 2
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- glucagon, glucagon-like peptide-1(7-36)amide, thyroid C cells, medullary thyroid carcinoma, calcitonin secretion, glucagon receptor, oxyntomodulin, cAMP production, receptor binding, calcium-dependent secretion
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Calcitonin, Glucagon-Like Peptides, Glucagon, Peptide Fragments, Perfusion, Thyroid Gland, Thyroid Neoplasms, Tumor Cells, Cultured, Rats, Wistar, Carcinoma, Medullary, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line. https://app.cochat.ai/papers/10.1210/endo.137.9.8756532
- The paper
- Crespel, A., De Boisvilliers, F., Gros, L., & Kervran, A. (1996). Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line. Endocrinology. https://doi.org/10.1210/endo.137.9.8756532
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.